prostate cancer

64yo male, 210 lbs, no ED issues. For about a year my PSA has been hovering around 4.22. Both my PCP and Defy will not continue to prescribe testosterone unless testing shows me clear of prostate cancer (PC). I was referred to a urologist and had my appointment today. The NP stated...

In this insightful episode of our podcast, we delve into a controversial and highly relevant topic in the realm of prostate cancer – the classification and implications of Gleason 6 prostate cancer. Our guest, Dr. Scott Eggener, a renowned co-director of the U Chicago Medicine High Risk and...

1:48 Diagnosis of Prostate Cancer is the tip of the iceberg 2:41 Can we prevent Prostate Cancer? 2:54 What about diet? 3:59 Should men start getting MRI's of their prostate starting at age 40? 5:30 How likely is the average person to be diagnosed with low-grade prostate cancer? 5:55 Is...

Dr. Mulhall is very thorough and on point as usual! In this video, Dr. John Mulhall discusses the impact of prostate cancer treatment on sexual health. He emphasizes the importance of fully informed consent and realistic expectations before treatment. He explains the common sexual...

We are delighted to team up with Clinical Laserthermia Systems Americas this week for a groundbreaking episode where we dive into the world of cutting-edge medical technology and shed light on an emerging innovation that promises to revolutionize the management of prostate cancer! CLS is a...

In this video, Dr. Richard Roehr and Dr. Lauren Walker discuss the challenges and side effects of Androgen Deprivation Therapy (ADT), also known as hormone therapy, for prostate cancer patients. They highlight the psychological and physical side effects, including loss of sex drive, fatigue, hot...

Loved this one! True Warrior! “If we continue to do the same things, we will get the same results.” “If BAT can be used to sensitive Xtandi/darolutamide ad infinitum, prostate cancer becomes a treatable condition like diabetes.” – Russ Hollyer Meeting Summary Advanced prostate...

This webinar discusses penile rehabilitation after prostate cancer treatment. The speaker shares her personal and professional journey as a sexologist and nurse practitioner, highlighting the importance of sexual health after cancer. The program she offers aims to educate, support, and provide...

Now that was deep! In this video, Dr. Eugene Kwon discusses advanced prostate cancer treatments. He emphasizes the importance of offering a full spectrum of diagnostics and therapeutics to patients. He clarifies misconceptions about standard of care, guidelines, and clinical trials. Dr. Kwon...

Article on pg.15 (PDF) Testosterone Replacement After Definitive Prostate Cancer Treatment: Where Do We Stand? Testosterone deficiency is defined by low circulating testosterone levels and the presence of attributable symptoms.1 The true incidence is unknown due to variation and controversy...

https://www.wjhg.com/video/2023/09/28/prostate-cancer-awareness/

In this episode, we challenge the terminology: Should Gleason 6 prostate conditions honestly be labeled as "cancer"? Many experts, including our esteemed guest, Dr. Adam Kibble - Chair of Urology at Harvard Medical School and Dana-Farber - believe the answer is a resounding "no." Delve deep into...

In this video, Dr. Aday discusses the latest advancements in active surveillance for prostate cancer. He explains the history of prostate cancer diagnosis and the limitations of the PSA test. He outlines the criteria for eligibility for active surveillance and the protocol for monitoring...

https://www.urologyhealth.org/educational-materials/prostate-health-playbook

This video is a talk about the physics basics of HDR brachytherapy for urologists. The speaker discusses the technology involved in HDR brachytherapy, including the afterloader and the use of imaging modalities such as ultrasound for treatment planning. Real-time image guidance allows for...

This video webinar discusses the prognosis and survival rates of prostate cancer. The speaker explains that prostate cancer is the most common cancer in men and that survival rates depend on the stage and type of cancer. For localized prostate cancer, the survival rate after five years is almost...

Prostate cancer is one of the most common cancers that affect men.

https://www.newswise.com/articles/desai-sethi-urology-institute-researcher-finds-sneaky-testosterone-might-signal-worse-outcomes-for-men-with-prostate-cancer...

Ashley E. Ross, MD, PhD, discusses the novel nomograms he and his team at Northwestern Medicine developed. The nomograms incorporate multiparametric prostate MRI, serum biomarkers and patient clinicodemographic features to help clinicians risk stratify patients with elevated PSA of 2–20 ng/mL...

In this video, a urologist discusses the use of MRI in the diagnosis and treatment of prostate cancer. MRIs are used to direct treatment decisions, assess the extent of cancer, and detect recurrences. The urologist explains how the MRI process works, the different imaging sequences used, and the...

The video discusses the innovations and advances in brachytherapy (a form of radiation therapy) for the treatment of prostate cancer. The speaker emphasizes the importance of personalized treatment and the use of MRI and automation in improving the efficiency and safety of brachytherapy...

https://www.urotoday.com/video-lectures/pcf-2022/video/2959-bipolar-androgen-therapy-in-the-management-of-prostate-cancer-samuel-denmeade.html Samuel Denmeade, Co-Director of the Johns Hopkins Prostate Cancer Program joins Alicia Morgans in a discussion on Bipolar Androgen Therapy (BAT) for...

18:44-32:10 Surgery video of Robotic Prostatectomy (graphic) Key Takeaways: Dr. Garrett Pullman, a urologist, is giving a presentation on robotic-assisted surgery for prostate cancer. Robotic-assisted surgery has transformed the treatment of prostate cancer, offering advantages such as...

Summary Dr. Samuel Denmead discusses the use of testosterone therapy to treat aggressive metastatic prostate cancer. By administering high doses of testosterone in a bipolar fashion, where levels fluctuate between super physiological and low, it has shown promising results in shrinking tumors...

Summary Prostate Cancer Lab #56 focuses on Bipolar Androgen Therapy (BAT) as a potential treatment for castration-resistant prostate cancer. The therapy involves alternating between high-dose testosterone injections and the continuation of testosterone-suppressing drugs. BAT has shown positive...

The review discusses the growing concern about cardiovascular complications arising from androgen deprivation therapy (ADT) for prostate cancer patients. These complications are not solely due to androgen suppression, as specific types of ADT lead to distinct cardiovascular issues. The purpose...

https://pcri.org/

PCRI's Alex and medical oncologist Mark Scholz, MD, describe the ins and outs of testosterone, especially as it concerns men with prostate cancer concerns. 0:06 How are testosterone levels measured? When is testosterone monitoring relevant in the context of prostate cancer? 1:44 What is the...